Literature DB >> 10082233

Naltrexone affects cocaine self-administration in naïve rats through the ventral tegmental area rather than dopaminergic target regions.

N F Ramsey1, M A Gerrits, J M Van Ree.   

Abstract

Behavioural studies have shown an involvement of central endogenous opioid systems in experimental cocaine addiction. Seeking to further localize the attenuating effect of opioid blockade on the reinforcing effects of cocaine, naltrexone was administered locally to different regions of the mesocorticolimbic system, which are thought to be critically involved in cocaine self-administration behaviour. Both cell body and nerve terminal regions of this system were targeted. Using a model for the initiation of cocaine self-administration behaviour, no effect of naltrexone was found in caudate, amygdaloid or accumbens nuclei, nor in the medial prefrontal cortex. However, blockade of endogenous opioid receptors in the ventral tegmental area region attenuated cocaine self-administration. With the initiation model, this finding reflects an attenuating effect on the reinforcing effects of cocaine. The attenuation of self-administration was dependent on the naltrexone dose. The present findings suggest that endogenous opioid systems in the ventral tegmental area modulate the reinforcing efficacy of cocaine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082233     DOI: 10.1016/s0924-977x(98)00009-1

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  11 in total

1.  Interactions between opioids and cocaine on locomotor activity in rats: influence of an opioid's relative efficacy at the mu receptor.

Authors:  Mark A Smith; Keith A Gordon; Christopher K Craig; Paul A Bryant; M Eric Ferguson; Adam M French; Jason D Gray; Jacob M McClean; Jonathan C Tetirick
Journal:  Psychopharmacology (Berl)       Date:  2003-04-01       Impact factor: 4.530

2.  Cellular learning theory: theoretical comment on Cole and McNally (2007).

Authors:  K Matthew Lattal; Rick E Bernardi
Journal:  Behav Neurosci       Date:  2007-10       Impact factor: 1.912

Review 3.  The opioid receptors as targets for drug abuse medication.

Authors:  Florence Noble; Magalie Lenoir; Nicolas Marie
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

4.  Self-administered heroin and cocaine combinations in the rat: additive reinforcing effects-supra-additive effects on nucleus accumbens extracellular dopamine.

Authors:  James E Smith; Conchita Co; Michael D Coller; Scott E Hemby; Thomas J Martin
Journal:  Neuropsychopharmacology       Date:  2006-01       Impact factor: 7.853

Review 5.  [The endogenous opioid system and drug addiction].

Authors:  R Maldonado
Journal:  Ann Pharm Fr       Date:  2010-01-21

6.  Microinjection of the delta-opioid receptor selective antagonist naltrindole 5'-isothiocyanate site specifically affects cocaine self-administration in rats responding under a progressive ratio schedule of reinforcement.

Authors:  Sara Jane Ward; David C S Roberts
Journal:  Behav Brain Res       Date:  2007-05-18       Impact factor: 3.332

7.  Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine.

Authors:  Sunmee Wee; Laura Orio; Senait Ghirmai; John R Cashman; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2009-05-30       Impact factor: 4.530

Review 8.  Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction.

Authors:  T S Shippenberg; A LeFevour; V I Chefer
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388

9.  Cocaine reward and hyperactivity in the rat: sites of mu opioid receptor modulation.

Authors:  A R Soderman; E M Unterwald
Journal:  Neuroscience       Date:  2008-05-03       Impact factor: 3.590

10.  Rearing environment differentially modulates cocaine self-administration after opioid pretreatment: A behavioral economic analysis.

Authors:  Rebecca S Hofford; Joshua S Beckmann; Michael T Bardo
Journal:  Drug Alcohol Depend       Date:  2016-08-03       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.